Clinical Trials

120 enrolled

Uterine Cervical Neoplasms

NCT07454720 2026-03-06

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT06860269 2026-02-10

GRAALL-2024

LymphoidOther hematologic neoplasm

1,200 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07392892 2026-02-06

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

840 enrolled

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT07226999 2026-01-12

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

550 enrolled

Small Cell Lung Carcinoma

NCT04681417 2025-11-28

RETINO 2018

225 enrolled

Other solid neoplasm

Retinoblastoma

NCT06341998 2025-09-19

SCRRYST

32 enrolled

Neoplasms, Germ Cell and Embryonal, Endodermal Sinus Tumor

NCT06624644 2025-09-10

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Phase 2/3 Active not recruiting

135 enrolled

Dermatologic

Melanoma

NCT07145333 2025-09-08

Drug-SNP

600 enrolled

Phase 2/3 Active not recruiting

SCLC

NCT01064466 2025-07-24

Drugs-SNPs

600 enrolled

Neoplasms, Small Cell Lung Carcinoma

NCT04082364 2025-06-08

MAHOGANY

82 enrolled 22 charts

Stomach Neoplasms

NCT07000253 2025-06-02

OMEC-5

290 enrolled

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT02807181 2025-05-09

SIRCCA

Phase 2/3 Terminated

89 enrolled 23 charts

Cholangiocarcinoma

NCT06907602 2025-04-02

ONTRESCC

120 enrolled

Esophageal Squamous Cell Carcinoma

NCT05255653 2024-11-29

RAINBO

1,615 enrolled

Endometrial Neoplasms

NCT06556550 2024-08-16

Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care

100 enrolled

Oligometastatic Disease

NCT05833815 2024-08-13

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

56 enrolled

Gallbladder Neoplasms

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

60 enrolled

Head & Neck

Mouth Neoplasms

NCT00837265 2024-04-03

NEUGR-002

334 enrolled 16 charts

Chemotherapy-induced Neutropenia

NCT01515787 2024-02-02

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

1,194 enrolled 25 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT05809336 2023-04-12

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

172 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT00096460 2023-01-05

BMT CTN 0202

Phase 2/3 Terminated

30 enrolled 5 charts

Lymphoid

Lymphoma, Follicular

NCT03410693 2022-09-28

FORT-1

175 enrolled 19 charts

Genitourinary

Carcinoma, Transitional Cell

NCT05409417 2022-06-08

Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status

40 enrolled

Colorectal Neoplasms

NCT04795596 2022-04-15

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

Phase 2/3 Withdrawn

Ovarian Neoplasms

NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

338 enrolled

Rectal Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

130 enrolled

Breast

Breast Neoplasms

NCT05209256 2022-01-26

Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC

90 enrolled

NSCLC

NCT03008148 2021-05-11

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

288 enrolled

CNS

Glioblastoma

NCT04677673 2020-12-21

RJGC-Senile

232 enrolled

Stomach Neoplasms

NCT02856048 2019-12-17

PRESOV

11 enrolled

LymphoidSarcoma

Lymphoma, Neoplasms, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02451774 2018-05-09

PTX-II

LymphoidOther hematologic neoplasm

44 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03399253 2018-01-16

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

120 enrolled

Stomach Neoplasms

NCT03344068 2017-12-22

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

408 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02606539 2017-03-22

SVCGTN

20 enrolled

Gestational Trophoblastic Disease

NCT01829178 2015-05-13

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

30 enrolled

Gastrointestinal Neoplasms

NCT00785421 2015-01-08

PROSPECT

312 enrolled

Pancreatic Neoplasms

NCT02240771 2014-09-16

Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma

124 enrolled

Carcinoma, Hepatocellular

NCT01438450 2012-07-13

OTCHCC

74 enrolled

Carcinoma, Hepatocellular

NCT00243685 2012-01-26

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

BreastGynecologicSarcomaThoracic

150 enrolled

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma

NCT01402180 2011-07-26

Nimotuzumab

128 enrolled

Esophageal Squamous Cell Carcinoma

NCT01015261 2010-11-22

Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients